| dbo:abstract
|
- Fluacizine, sold under the brand name Phtorazisin, is a tricyclic antidepressant (TCA) of the phenothiazine group which is or was marketed in Russia. Unlike other phenothiazines, fluacizine is not an antipsychotic, and can actually reverse catalepsy and extrapyramidal symptoms induced by antidopaminergic agents like antipsychotics, reserpine, and tetrabenazine as well as potentiate amphetamine-induced stereotypy. It is known to act as a norepinephrine reuptake inhibitor, antihistamine, and anticholinergic. The drug was developed in the 1960s and was marketed in the 1970s. It is the trifluoromethyl analogue of chloracizine. (en)
- Фторацизин (Phthoracizinum) — 2-Трифторметил-10-(3-диэтиламино-пропионил)-фенотиазина гидрохлорид. Синоним: Fluacizine. (ru)
|
| dbo:alternativeName
| |
| dbo:casNumber
|
- 27312-93-2 (hydrochloride)
- 30223-48-4
|
| dbo:chEMBL
| |
| dbo:fdaUniiCode
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 5298 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:alt
|
- Skeletal formula of fluacizine (en)
- Space-filling model of the fluacizine molecule (en)
|
| dbp:atcPrefix
| |
| dbp:c
| |
| dbp:casNumber
| |
| dbp:casSupplemental
| |
| dbp:chembl
| |
| dbp:chemspiderid
| |
| dbp:f
| |
| dbp:h
| |
| dbp:image
|
- Fluacizine 3D spacefill.png (en)
|
| dbp:iupacName
| |
| dbp:legalStatus
| |
| dbp:n
| |
| dbp:o
| |
| dbp:pubchem
| |
| dbp:routesOfAdministration
| |
| dbp:s
| |
| dbp:smiles
| |
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- VHEOUJNDDFHPGJ-UHFFFAOYSA-N (en)
|
| dbp:synonyms
|
- Fluoracizine; Fluoracyzine; Fluoracisine; Ftoracizin; Ftoracizine; Phthoracizin (en)
|
| dbp:title
| |
| dbp:titlestyle
| |
| dbp:tradename
| |
| dbp:unii
| |
| dbp:verifiedrevid
| |
| dbp:watchedfields
| |
| dbp:width
|
- 200 (xsd:integer)
- 250 (xsd:integer)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Fluacizine, sold under the brand name Phtorazisin, is a tricyclic antidepressant (TCA) of the phenothiazine group which is or was marketed in Russia. Unlike other phenothiazines, fluacizine is not an antipsychotic, and can actually reverse catalepsy and extrapyramidal symptoms induced by antidopaminergic agents like antipsychotics, reserpine, and tetrabenazine as well as potentiate amphetamine-induced stereotypy. It is known to act as a norepinephrine reuptake inhibitor, antihistamine, and anticholinergic. The drug was developed in the 1960s and was marketed in the 1970s. It is the trifluoromethyl analogue of chloracizine. (en)
- Фторацизин (Phthoracizinum) — 2-Трифторметил-10-(3-диэтиламино-пропионил)-фенотиазина гидрохлорид. Синоним: Fluacizine. (ru)
|
| rdfs:label
|
- Fluacizine (en)
- Фторацизин (ru)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
